Drug comparisons
Insulin Aspart Human vs Rosiglitazone
Insulin Aspart is a rapid-acting injectable insulin for blood sugar control in diabetes, while Rosiglitazone is an oral medication that improves insulin sensitivity.
No comparison dimensions are available for this page.
Clinical context
Patients with diabetes are comparing Insulin Aspart and Rosiglitazone when deciding between injectable and oral antidiabetic therapies.
Bottom line
The choice between Insulin Aspart and Rosiglitazone depends on the patient's specific diabetes type and needs rather than one being better overall.
All medication comparisons